• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/21/14

    • 30-Day SEC Yield1

      -0.14%
    • Total Net Assets

      $557.4M
    • Number of Holdings

      27
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 10/21/14

    • % of Net Assets
    • Stocks

      99.88
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.12
  • Download All HoldingsAll Holdings (%)as of 10/21/14

    Total Holdings: 27
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    810,054
    86,408,46015.50
    Amgen Inc
    AMGN US
    448,950
    64,689,20611.61
    Celgene Corp
    CELG US
    560,740
    53,253,4789.55
    Biogen Idec Inc
    BIIB US
    141,430
    46,215,0818.29
    Alexion Pharmaceuticals Inc
    ALXN US
    167,609
    29,243,5805.25
    Vertex Pharmaceuticals Inc
    VRTX US
    263,753
    28,527,5245.12
    Regeneron Pharmaceuticals Inc
    REGN US
    70,523
    26,869,9684.82
    Illumina Inc
    ILMN US
    140,270
    25,185,4794.52
    Biomarin Pharmaceutical Inc
    BMRN US
    277,510
    20,732,7723.72
    Pharmacyclics Inc
    PCYC US
    161,096
    18,777,3503.37
    Medivation Inc
    MDVN US
    192,203
    18,637,9253.34
    Incyte Corp Ltd
    INCY US
    348,224
    18,260,8673.28
    Qiagen Nv
    QGEN US
    758,408
    17,124,8533.07
    United Therapeutics Corp
    UTHR US
    109,740
    14,003,9212.51
    Puma Biotechnology Inc
    PBYI US
    51,350
    11,711,9082.10
    Cubist Pharmaceuticals Inc
    CBST US
    167,582
    11,127,4452.00
    Covance Inc
    CVD US
    120,995
    9,729,2081.75
    Alkermes Plc
    ALKS US
    211,599
    9,268,0361.66
    Isis Pharmaceuticals Inc
    ISIS US
    222,086
    9,132,1761.64
    Intercept Pharmaceuticals Inc
    ICPT US
    37,714
    8,512,4271.53
    Charles River Laboratories Internationa
    CRL US
    121,913
    7,586,6461.36
    Nps Pharmaceuticals Inc
    NPSP US
    235,800
    6,765,1021.21
    Cepheid Inc
    CPHD US
    132,435
    6,375,4211.14
    Myriad Genetics Inc
    MYGN US
    126,751
    4,649,2270.83
    Seattle Genetics Inc
    SGEN US
    111,954
    3,953,0960.71
    Other/Cash
    643,4190.12
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.